文献速递糖尿病

东亚人群2型糖尿病与糖尿病肾病的DNA甲基化改变

DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究在韩国人群中开展全甲基化组关联研究,纳入232例2型糖尿病患者和197例非糖尿病对照,鉴定出8个与2型糖尿病风险相关的差异甲基化位点(DMS),其中5个为新位点;另鉴定出3个与糖尿病肾病相关的DMS。部分DMS与空腹血糖和糖化血红蛋白相关,孟德尔随机化提示空腹血糖与CPT1A的DMS存在因果关联。

要点

  • 鉴定出8个与2型糖尿病相关的DMS,其中5个为新CpG位点。
  • 鉴定出3个与糖尿病肾病相关的DMS,但与2型糖尿病DMS未见显著重叠。
  • TXNIP和CPT1A的DMS与空腹血糖及糖化血红蛋白相关。

核心结论

  • 在东亚人群中鉴定出8个与2型糖尿病相关的DMS(含5个新CpG位点)和3个与糖尿病肾病相关的DMS,均达到全甲基化组统计学显著性。

研究设计与样本

  • 在232例2型糖尿病患者和197例非糖尿病对照的外周血白细胞中,使用Illumina EPIC bead chip进行全甲基化组关联研究。
  • 2型糖尿病组进一步分为87例糖尿病肾病患者和80例非糖尿病肾病患者。
  • 另纳入2个人群队列的819名个体,用于分析已鉴定DMS与定量代谢表型的关联。
  • 采用孟德尔随机化方法评估代谢表型对已鉴定DMS的因果效应。

主要发现

  • 鉴定出8个与2型糖尿病风险显著相关的DMS(P < 9.0 × 10-8),分别位于BMP8A、NBPF20、STX18、ZNF365、CPT1A、TRIM37(各1个)和TXNIP(2个),其中TXNIP和CPT1A的3个DMS为已知位点。
  • 鉴定出3个与糖尿病肾病相关的DMS,分别位于COMMD1、TMOD1和FHOD1。
  • 由于样本量有限,未观察到2型糖尿病与糖尿病肾病的DMS之间存在显著重叠。
  • TXNIP和CPT1A的DMS与空腹血糖和糖化血红蛋白A1c相关。
  • 孟德尔随机化分析显示,空腹血糖与CPT1A的DMS存在因果关联。

临床怎么用

  • TXNIP和CPT1A的DMS与空腹血糖及糖化血红蛋白相关,提示其作为2型糖尿病相关甲基化标志物的潜在价值。
  • 孟德尔随机化提示空腹血糖对CPT1A的DMS有因果效应,为血糖控制与表观遗传改变的联系提供线索。

局限性

  • 样本量有限,未能观察到2型糖尿病与糖尿病肾病的DMS之间的显著重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is a growing body of evidence that epigenetic changes including DNA methylation influence the risk of type 2 diabetes (T2D) and its microvascular complications. OBJECTIVE: We conducted a methylome-wide association study (MWAS) to identify differentially methylated sites (DMSs) of T2D and diabetic kidney disease (DKD) in a Korean population. METHODS: We performed an MWAS in 232 participants with T2D and 197 nondiabetic controls with the Illumina EPIC bead chip using peripheral blood leukocytes. The T2D group was subdivided into 87 DKD patients and 80 non-DKD controls. An additional 819 individuals from 2 population-based cohorts were used to investigate the association of identified DMSs with quantitative metabolic phenotypes. A mendelian randomization (MR) approach was applied to evaluate the causal effect of metabolic phenotypes on identified DMSs. RESULTS: We identified 8 DMSs (each at BMP8A, NBPF20, STX18, ZNF365, CPT1A, and TRIM37, and 2 at TXNIP) that were significantly associated with the risk of T2D (P < 9.0 × 10-8), including 3 that were previously known (DMSs in TXNIP and CPT1A). We also identified 3 DMSs (in COMMD1, TMOD1, and FHOD1) associated with DKD. With our limited sample size, we were not able to observe a significant overlap between DMSs of T2D and DKD. DMSs in TXNIP and CTP1A were associated with fasting glucose and glycated hemoglobin A1c. In MR analysis, fasting glucose was causally associated with DMS in CPT1A. CONCLUSION: In an East Asian population, we identified 8 DMSs, including 5 novel CpG loci, associated with T2D and 3 DMSs associated with DKD at methylome-wide statistical significance.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kim H, Bae JH, Park KS, et al. DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population. J Clin Endocrinol Metab. 2021. PMID: 34214161. doi:10.1210/clinem/dgab488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。